ESPERION THERAPEUTICS, INC. (ESPR) SEC News March 10, 2026, 11:17 UTC 2 1 comments (30% Negative) ESPERION THERAPEUTICS, INC. (ESPR) Reports Q1 2026 Financial Results Comment Full text
PASSAGE BIO, INC. (PASG) SEC News March 10, 2026, 11:15 UTC 2 1 comments (99% Neutral) PASSAGE BIO, INC. (PASG) Announces Business Combination Comment Full text
Q32 BIO INC. (QTTB) SEC News March 10, 2026, 11:05 UTC 2 1 comments (30% Negative) Q32 BIO INC. (QTTB) Reports Q1 2026 Financial Results Comment Full text
APYX MEDICAL CORPORATION (APYX) SEC News March 10, 2026, 11:01 UTC 2 1 comments (30% Negative) APYX MEDICAL CORPORATION (APYX) Reports Q1 2026 Financial Results Comment Full text
ZURA BIO LIMITED (ZURA) SEC News March 10, 2026, 10:40 UTC 3 1 comments (10% Negative) ZURA BIO LIMITED (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Top Glove Corporation BHD (BVA) SEC News March 10, 2026, 10:26 UTC 2 0 comments General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016 Comment Full text
Top Glove Corporation BHD (BVA) SEC News March 10, 2026, 10:26 UTC 2 0 comments General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016 Comment Full text
Top Glove Corporation BHD (BVA) SEC News March 10, 2026, 10:25 UTC 2 0 comments General Announcement: DEALINGS DURING CLOSED PERIOD Comment Full text
EXAGEN INC. (XGN) SEC News March 10, 2026, 10:23 UTC 2 0 comments New Form 10-K - EXAGEN INC. <b>Filed:</b> 2026-03-10 <b>AccNo:</b> 0001274737-26-000009 <b>Size:</b> 12 MB Comment Full text
LIPOCINE INC. (LPCN) SEC News March 10, 2026, 10:13 UTC 3 1 comments (90% Positive) LIPOCINE INC. (LPCN) Reports Q1 2026 Financial Results Comment Full text